Exxon Mobil Corp. (XOM) Falls 2.81% for January 19

Equities Staff |

One of the S&P 500’s big losers for Tuesday January 19 was Exxon Mobil Corp. (XOM). The company’s stock fell 2.81% to $75.40 on volume of 16.29 million shares.

The stock opened the day at 77.93 and traded between a low of $75.19 and a high of $78.24. The stock finished the day down $2.18 per share. Exxon Mobil Corp. has an average daily volume of 15.62 million and a total float of 4.16 billion shares. The 50-day SMA for Exxon Mobil Corp. is $78.87 and its 200-day SMA is $79.74. The high for the stock over the last 52 weeks is $93.45 and the low is $66.55.

Exxon Mobil Corporation is engaged in energy, involving exploration for, and production of, crude oil and natural gas, manufacture of petroleum products and transportation and sale of crude oil, natural gas and petroleum products.

Exxon Mobil Corp. is centered in Irving, TX, and has 75,300 employees. Today’s trading day leaves the company with a market cap of $313.89 billionwith a P/E Ratio of 16.4. The company has a P/S ratio of 1.54, P/B ratio of 1.84, and a -220.5.

For a complete fundamental analysis analysis of Exxon Mobil Corp., check out Equities.com’s Stock Valuation Analysis report for XOM. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

GSV Capital Corp

GSV Capital Corp is an externally managed, non-diversified closed-end management investment company. The Company has elected to be treated as a business development company.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…